Zobrazeno 1 - 10
of 22
pro vyhledávání: '"K O, Zupanets"'
Publikováno v:
Zaporožskij Medicinskij Žurnal, Iss 2, Pp 93-98 (2016)
Protection of rights, health and well-being of persons who are taking the drug during the trial (trial subjects) is one of the basic principles of clinical trials (CT) management. Aim. In order to study key aspects of volunteer protection, determi
Externí odkaz:
https://doaj.org/article/f420d4cbfeb94056ab278fbac6c34ecf
Autor:
K. O. Zupanets, T. S. Sakharova, N. P. Bezugla, I. A. Otrishko, S. K. Shebeko, K. L. Ratushna
Publikováno v:
Фармацевтичний часопис. :63-72
Мета роботи. Оптимізація та удосконалення фармацевтичної опіки для забезпечення раціональної фітотерапії пацієнтів при симптоматично
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98a04147c45378351f67b806087062ea
https://doi.org/10.11603/2312-0967.2021.4.12634
https://doi.org/10.11603/2312-0967.2021.4.12634
Publikováno v:
Clinical pharmacy. 25:24-31
Diseases of the respiratory system occupy an important place in the structure of morbidity in the population of Ukraine, being only second to diseases of the cardiovascular system in prevalence. Patients with a respiratory pathology make up a signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb32ff4a1d595858f8117d8cd4bc0119
https://doi.org/10.24959/cphj.21.1545
https://doi.org/10.24959/cphj.21.1545
Publikováno v:
Clinical pharmacy. 24:4-14
For many years, acute respiratory viral infections and influenza have remained a serious medical and social health problem as a leading cause of missing days at work by adults and schools or kindergartens by children, increased costs of medical care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::244e30d2119e51a1918d86acc9f54161
https://doi.org/10.24959/cphj.20.1530
https://doi.org/10.24959/cphj.20.1530
Publikováno v:
Accreditation and Quality Assurance. 25:383-386
The importance of the appropriate sample management in regulated bioanalyses is undeniable for clinical and non-clinical study support due to the fact that if samples are compromised at any stage prior to the analysis, the study results may be affect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2aa8625b2f065a14d2d27383649d4d91
https://doi.org/10.1007/s00769-020-01448-2
https://doi.org/10.1007/s00769-020-01448-2
Publikováno v:
Die Pharmazie. 77(1)
Combined dry extract BNO 1016 is a herbal drug commonly used for rhinosinusitis therapy. It is known that a significant role in rhinosinusitis pathogenesis is played by an inflammatory reaction in maxillary sinuses of the nasal cavity. At the initial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de885167cfa962d4b3dbe3f90bb6fe83
https://pubmed.ncbi.nlm.nih.gov/35045922
https://pubmed.ncbi.nlm.nih.gov/35045922
Publikováno v:
Scientia Pharmaceutica
Volume 89
Issue 3
Scientia Pharmaceutica, Vol 89, Iss 32, p 32 (2021)
Volume 89
Issue 3
Scientia Pharmaceutica, Vol 89, Iss 32, p 32 (2021)
Expectorant phytomucolytic syrups are widely used pediatric OTC-medicines. Physicians, pediatricians, and pharmacists are traditionally concerned with the efficacy of the active ingredients in cough syrups, and rarely consider the safety aspects of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645c23cd5f542b3fd2f895bed2afe38d
Publikováno v:
Clinical pharmacy. 23:38-44
A risk–based approach to the quality of clinical trial (CT) data provides the appropriate conditions for the use of materials at clinical trial site (CTS). One of the most important parameters requires careful monitoring of the temperature mode for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a90046324956ca5165b95011787f7ed
https://doi.org/10.24959/cphj.19.1508
https://doi.org/10.24959/cphj.19.1508
Publikováno v:
Klìnìčna farmacìâ. 23:38-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388d10257cf29101246d3477ae4d5eb7
https://doi.org/10.24959/cphj.19.1498
https://doi.org/10.24959/cphj.19.1498
Publikováno v:
Scientia Pharmaceutica, Vol 88, Iss 47, p 47 (2020)
Scientia Pharmaceutica
Volume 88
Issue 4
Scientia Pharmaceutica
Volume 88
Issue 4
(1) Background: this research aims at studying the nephroprotective properties of BNO 2103 in a model of chromate-induced renal failure in rats and at proving the possibility of using BNO 2103 in clinical practice for the complex treatment of chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e329880967c6adeb83c5cfa9208ff485
https://www.mdpi.com/2218-0532/88/4/47
https://www.mdpi.com/2218-0532/88/4/47